ChulaCov19 mRNA Vaccine in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04566276

Recruitment Status : Not yet recruiting

First Posted : September 28, 2020

Last Update Posted : October 6, 2020

See Contacts and Locations

Sponsor:

Collaborators:

Center of Excellence in Vaccine Research and Development, Chulalongkorn University

Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine, Mahidol University

Chula Vaccine Research Center (ChulaVRC), Faculty of Medicine, Chulalongkorn University

National Vaccine Institute (NVI), Thailand

National Research Council of Thailand

C2F Chulalongkorn University, Faculty of Medicine, Chulalongkorn University

Information provided by (Responsible Party):

Chulalongkorn University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Not yet recruiting
Estimated Primary Completion Date :	March 2021
Estimated Study Completion Date :	June 2021

To Top